Law ❯ Regulatory Compliance

FDA Regulations

Drug Approval Process Biologics License Application Corporate Inspections Promotional Practices New Drug Application Clinical Trials Compounded Drugs Cosmetic Products Citizen Petitions Risk Evaluation Risk Management Product Safety Risk Evaluation and Mitigation Strategy (REMS) Drug Advertising Drug Safety

Investors Vie to Lead ImmunityBio Securities Suit

An FDA warning about misleading Anktiva promotions has turned investor losses into the central issue in the fight over who will control the case.

Class Action Filed Against Atara Biotherapeutics Over Alleged Misstatements on FDA Setbacks

Atara Investors Get May 22 Deadline to Seek Lead Role in Securities Suit

Investor Class Actions Target Atara Over FDA Setbacks to EBVALLO

GOP Senators Press FDA on Illegal Online Abortion Pill Sales, Launch Probe of Mifepristone Makers

Cytokinetics Investors Face Nov. 17 Deadline to Seek Lead Role in Aficamten Securities Case

Kenvue Asks FDA to Reject Autism Warning on Tylenol in Pregnancy

Investor Firms Urge Cytokinetics Shareholders to Seek Lead Role in FDA-Disclosure Suit Before Nov. 17

Cytokinetics Hit With Securities Class Action Over Aficamten Timeline Disclosures